Severity of urinary incontinence and effect on quality of life in women by incontinence type.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 3959868)

Published in Obstet Gynecol on May 01, 2013

Authors

Vatche A Minassian1, Elizabeth Devore, Kaitlin Hagan, Francine Grodstein

Author Affiliations

1: Director of Urogynecology, Department of OB/GYN, Brigham and Women’s Hospital, Boston, MA 02115, USA. vminassian@partners.org

Articles citing this

Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med (2015) 0.88

The Michigan Incontinence Symptom Index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence. Neurourol Urodyn (2013) 0.85

Treatment status and risk factors for incidence and persistence of urinary incontinence in women. Int Urogynecol J (2014) 0.81

The interaction of stress and urgency urinary incontinence and its effect on quality of life. Int Urogynecol J (2014) 0.78

Hidden prevalence of lower urinary tract symptoms in healthy nulligravid young women. Int Urogynecol J (2015) 0.76

Conservative Management of Urinary Incontinence in Women. Rev Urol (2015) 0.75

What Is the Real Impact of Urinary Incontinence on Female Sexual Dysfunction? A Case Control Study. Sex Med (2017) 0.75

Epidemiology of mixed, stress, and urgency urinary incontinence in middle-aged/older women: the importance of incontinence history. Int Urogynecol J (2015) 0.75

The Prevalence, Subtypes and Obstetric Risk Factors of Urinary Incontinence in Reproductive Age Women Referred to Community Health Care Centers of Dezful, Iran- 2015. Int J Community Based Nurs Midwifery (2017) 0.75

Urinary Incontinence, Its Risk Factors, and Quality of Life: A Study among Women Aged 50 Years and above in a Rural Health Facility of West Bengal. J Midlife Health (2017) 0.75

Association between waist-to-height ratio and postpartum urinary incontinence. Int Urogynecol J (2016) 0.75

Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence. J Urol (2017) 0.75

Change in urinary storage symptoms following treatment for female stress urinary incontinence. Int Urogynecol J (2016) 0.75

Clinical epidemiological insights into urinary incontinence. Int Urogynecol J (2017) 0.75

Articles cited by this

Prevalence of urinary incontinence. Br Med J (1980) 7.11

Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn (1995) 6.30

A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag. J Clin Epidemiol (2000) 6.09

Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health (1993) 4.03

Urinary incontinence in US women: a population-based study. Arch Intern Med (2005) 3.32

Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol (2011) 2.81

Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity. J Clin Epidemiol (1995) 2.69

Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc (1998) 2.59

Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study. Am J Obstet Gynecol (2003) 2.13

The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int (2003) 1.93

Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol (2008) 1.67

Epidemiology and natural history of urinary incontinence in women. Urology (2003) 1.66

The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age. Acta Obstet Gynecol Scand (2000) 1.63

Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc (1990) 1.62

Quality of life in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.49

Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn (2009) 1.39

Mixed incontinence is more bothersome than pure incontinence subtypes. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.19

Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol (2003) 1.15

Mixed urinary incontinence: greater impact on quality of life. J Urol (2009) 1.14

Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. Eur Urol (2006) 1.11

The impact of the overactive bladder on health-related utility and quality of life. BJU Int (2006) 1.05

Challenges in designing a pragmatic clinical trial: the mixed incontinence -- medical or surgical approach (MIMOSA) trial experience. Clin Trials (2009) 1.01

Why do stress and urge incontinence co-occur much more often than expected? Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.01

Clinical predictors of urinary incontinence in women. Am J Obstet Gynecol (1997) 0.99

The prevalence of urinary incontinence. Acta Obstet Gynecol Scand (2000) 0.96

The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J (2012) 0.93

Articles by these authors

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87

Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med (2005) 4.92

Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90

Physical activity at midlife in relation to successful survival in women at age 70 years or older. Arch Intern Med (2010) 4.45

Exposure to particulate air pollution and cognitive decline in older women. Arch Intern Med (2012) 3.78

Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45

Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am J Med (2003) 3.27

A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med (2006) 3.19

Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc (2005) 2.86

Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62

Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39

Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol (2012) 2.29

Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol (2006) 2.06

Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol (2003) 1.97

Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect (2008) 1.87

The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord (2006) 1.85

Mediterranean diet and cognitive function in older age. Epidemiology (2013) 1.85

Effects of marital transitions on changes in dietary and other health behaviours in US women. Int J Epidemiol (2004) 1.74

Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65

Risk factors for fecal incontinence in older women. Am J Gastroenterol (2012) 1.64

Physical activity and cognition in women with vascular conditions. Arch Intern Med (2011) 1.61

Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol (2009) 1.59

Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc (2011) 1.57

Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med (2004) 1.52

Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc (2011) 1.50

Body mass index, weight gain, and incident urinary incontinence in middle-aged women. Obstet Gynecol (2007) 1.44

Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc (2008) 1.44

The epidemiology of urinary incontinence in older women: incidence, progression, and remission. J Am Geriatr Soc (2008) 1.41

Incidence and remission of urinary incontinence in middle-aged women. Am J Obstet Gynecol (2007) 1.39

Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol (2005) 1.38

Urinary incontinence and prevalence of high depressive symptoms in older black versus white women. Int Urogynecol J (2014) 1.38

Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol (2012) 1.37

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37

Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ (2004) 1.36

Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34

Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2. Alzheimers Dement (2011) 1.29

Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol (2012) 1.23

BMI, waist circumference, and incident urinary incontinence in older women. Obesity (Silver Spring) (2008) 1.23

Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study. BMJ (2009) 1.22

Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. Circulation (2009) 1.22

Does caregiving stress affect cognitive function in older women? J Nerv Ment Dis (2004) 1.21

The incidence of urinary incontinence across Asian, black, and white women in the United States. Am J Obstet Gynecol (2009) 1.17

Type 2 diabetes mellitus and risk of stress, urge and mixed urinary incontinence. J Urol (2008) 1.15

Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors. J Acad Nutr Diet (2012) 1.15

Physical activity and urinary incontinence among healthy, older women. Obstet Gynecol (2007) 1.15

The relation of education and income to cognitive function among professional women. Neuroepidemiology (2005) 1.14

High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology (2006) 1.14

The association between dietary patterns at midlife and health in aging: an observational study. Ann Intern Med (2013) 1.14

Menopause and postmenopausal hormone use and risk of incident kidney stones. J Am Soc Nephrol (2003) 1.13

Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women. Neurology (2003) 1.13

Dietary antioxidants and long-term risk of dementia. Arch Neurol (2010) 1.11

Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging (2005) 1.08

Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum (2003) 1.07

Long-term adherence to the Mediterranean diet is associated with overall cognitive status, but not cognitive decline, in women. J Nutr (2013) 1.07

Prospective study of plasma folate, vitamin B12, and cognitive function and decline. Epidemiology (2006) 1.06

Relative telomere length and cognitive decline in the Nurses' Health Study. Neurosci Lett (2011) 1.04

Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis (2009) 1.03

Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr (2009) 1.02

Dietary fat intake and cognitive decline in women with type 2 diabetes. Diabetes Care (2009) 1.02

Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch Intern Med (2005) 1.02

Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch Neurol (2009) 1.01

Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging (2010) 1.00

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology (2004) 0.99

Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study. Arthritis Res Ther (2013) 0.99

Risk factors for urinary, fecal, or dual incontinence in the Nurses' Health Study. Obstet Gynecol (2013) 0.98

Performance characteristics of plasma amyloid-beta 40 and 42 assays. J Alzheimers Dis (2009) 0.98

Caffeine intake, and the risk of stress, urgency and mixed urinary incontinence. J Urol (2011) 0.97

Fasting insulin levels and cognitive decline in older women without diabetes. Neuroepidemiology (2008) 0.96

Plasma IGF-I levels and cognitive performance in older women. Neurobiol Aging (2005) 0.95

Alcohol consumption at midlife and successful ageing in women: a prospective cohort analysis in the nurses' health study. PLoS Med (2011) 0.94

Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis (2005) 0.94

Physical activity and incident urinary incontinence in middle-aged women. J Urol (2008) 0.92

Physical activity levels and cognition in women with type 2 diabetes. Am J Epidemiol (2009) 0.91

Sleep duration in midlife and later life in relation to cognition. J Am Geriatr Soc (2014) 0.90

Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses' Health Study. Ann Rheum Dis (2013) 0.90

Total antioxidant capacity of diet in relation to cognitive function and decline. Am J Clin Nutr (2010) 0.89

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial". Am J Epidemiol (2006) 0.89

Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women. Am J Obstet Gynecol (2008) 0.86

Seafood types and age-related cognitive decline in the Women's Health Study. J Gerontol A Biol Sci Med Sci (2013) 0.85

Midlife plasma insulin-like growth factor I and cognitive function in older men. J Clin Endocrinol Metab (2006) 0.85

The association of antioxidants and cognition in the Nurses' Health Study. Am J Epidemiol (2012) 0.85

Factors associated with persistent urinary incontinence. Am J Obstet Gynecol (2013) 0.83

Clinical research in diabetes and urinary incontinence: what we know and need to know. J Urol (2009) 0.83

Original research: rates of remission, improvement, and progression of urinary incontinence in Asian, Black, and White women. Am J Nurs (2011) 0.83

A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation. Int J Geriatr Psychiatry (2009) 0.83

Plasma C-peptide and cognitive performance in older men without diabetes. Am J Geriatr Psychiatry (2006) 0.83

Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence. Am J Cardiol (2002) 0.82

Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II. Neuroepidemiology (2010) 0.82

Plasma beta-amyloid level, cognitive reserve, and cognitive decline. JAMA (2011) 0.82

Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes. Psychoneuroendocrinology (2008) 0.82

The epidemiology of urinary incontinence in women with type 2 diabetes. J Urol (2012) 0.82

Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study. Alzheimer Dis Assoc Disord (2012) 0.81

Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease. Epidemiol Rev (2013) 0.81

Cumulative exposure to lead and cognition in persons with Parkinson's disease. Mov Disord (2012) 0.80

Relationship between hormone replacement therapy, socioeconomic status, and coronary heart disease. JAMA (2003) 0.80

Plasma carotenoids and tocopherols and cognitive function: a prospective study. Neurobiol Aging (2007) 0.79

The relation between moderate alcohol consumption and cognitive function in older women with type 2 diabetes. Diabetes Res Clin Pract (2009) 0.79

Postmenopausal hormone replacement therapy. Ann Intern Med (2003) 0.79

Phobic anxiety and cognitive performance over 4 years among community-dwelling older women in the Nurses' Health Study. Am J Geriatr Psychiatry (2013) 0.79